加州5个卫生区视频直接观察治疗监测结核治疗的评估
在美国加州5个卫生区,比较174例使用视频直接观察治疗(VDOT)与159例面对面直接观察治疗(DOT)的结核患者服药依从性。VDOT组观察到的预期剂量中位比例(FEDO)高于DOT组,且成本更低,多数患者偏好并推荐VDOT。
要点
- VDOT组FEDO中位数93.0%,高于DOT组的66.4%。
- 96%的参与者愿意向他人推荐VDOT,90%更偏好VDOT。
- VDOT成本比DOT低32%(范围6%-46%)。
核心结论
- VDOT在结核治疗监测中可行、可接受,依从性高且成本低于DOT。
研究设计与样本
- 在加州5个卫生区开展评估,比较174例VDOT患者与159例面对面DOT患者的依从性;采用多变量线性回归分析依从性相关因素。
主要发现
- VDOT组FEDO中位数为93.0%(IQR 83.4%-97.1%),DOT组为66.4%(IQR 55.1%-89.3%)。
- 参与者中位年龄44岁(范围18-87岁),61%为男性。
- 较低的FEDO独立关联于美国或墨西哥出生、VDOT持续时间较短、认为VDOT困难、经常离家服药及存在视频录制问题(p<0.05)。
临床怎么用
- 对结核患者可考虑采用VDOT替代面对面DOT以提高依从性并降低成本。
- 需关注视频录制问题、认为VDOT困难及经常离家服药者,针对性支持以提高依从性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We assessed video directly observed therapy (VDOT) for monitoring tuberculosis treatment in 5 health districts in California, USA, to compare adherence between 174 patients using VDOT and 159 patients using in-person directly observed therapy (DOT). Multivariable linear regression analyses identified participant-reported sociodemographics, risk behaviors, and treatment experience associated with adherence. Median participant age was 44 (range 18-87) years; 61% of participants were male. Median fraction of expected doses observed (FEDO) among VDOT participants was higher (93.0% [interquartile range (IQR) 83.4%-97.1%]) than among patients receiving DOT (66.4% [IQR 55.1%-89.3%]). Most participants (96%) would recommend VDOT to others; 90% preferred VDOT over DOT. Lower FEDO was independently associated with US or Mexico birth, shorter VDOT duration, finding VDOT difficult, frequently taking medications while away from home, and having video-recording problems (p<0.05). VDOT cost 32% (range 6%-46%) less than DOT. VDOT was feasible, acceptable, and achieved high adherence at lower cost than DOT.
引用
- Garfein RS, Liu L, Cuevas-Mota J, et al. Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA. Emerg Infect Dis. 2018. PMID: 30226154. doi:10.3201/eid2410.180459
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。